Screener
Protagonist Therapeutics PTGX PP&E (Net)
PP&E (Net) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 7,790 | 10,089 |
| Total current assets | 807,148 | 577,574 |
| Marketable securities - noncurrent | 66,875 | 78,638 |
| Property and equipment, net | 3,456 | 3,860 |
| Restricted cash - noncurrent | 287 | 287 |
| Operating lease right-of-use asset | 6,946 | 7,829 |
| Other non-current asset | 832 | — |
| Total assets | $885,544 | $668,188 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Protagonist Therapeutics's PP&E (net)?
- Protagonist Therapeutics (PTGX) reported PP&E (net) of $3.46M in Q2 2026.
- How has Protagonist Therapeutics's PP&E (net) changed year-over-year?
- Protagonist Therapeutics's PP&E (net) decreased by 15.9% year-over-year, from $4.11M to $3.46M.
- What is the long-term trend for Protagonist Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's PP&E (net) has grown at a 21.4% compound annual growth rate (CAGR), from $1.46M to $3.86M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Protagonist Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude